Stock Information

• Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
  Tue, Sep 29, 2026 7:30 AM
• CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
  Fri, Sep 25, 2026 8:50 PM
• CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As Book Value Questions Linger
  Fri, Sep 25, 2026 6:09 AM
• Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
  Thu, Sep 24, 2026 4:42 PM
• Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
  Thu, Sep 24, 2026 2:59 PM
• CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
  Thu, Sep 24, 2026 1:02 PM
• Anthropic AI Discovery Gene-Editing Stocks Falling
  Thu, Sep 24, 2026 12:46 PM
• CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
  Wed, Sep 23, 2026 9:49 PM
• Anthropic CEO Dario Amodei Posts On X "Today we announced the Claude-led discovery of a molecular machine that we suspect could represent a new gene editing mechanism. Its precise function, biotechnological utility (if any), or level of significance is not yet clear, but at minimum it is work I would have been proud to do as a PhD student. The work was done mostly, though not entirely, by Claude: our life sciences team suggested a broad area of research..."
  Wed, Sep 23, 2026 2:54 PM
• "Anthropic’s Biolab Made A Discovery It’s Comparing To Crispr; It Took Nearly 1,000 Claude Agents 21 Hours And 210 Million Tokens To Uncover The ‘Novel Enzyme System.’" - The Verge
  Wed, Sep 23, 2026 2:05 PM

Financial data not available